La. Appeals Court Backs Novartis In Schizophrenia Drug Suit

Law360, New York (June 17, 2015, 10:09 PM EDT) -- A Louisiana state appeals court on Wednesday reversed a lower court's judgment against Novartis Pharmaceutical Corp. in an injury suit over the allegedly serious side effects of its schizophrenia medication Clorazil that a Louisiana man had claimed caused seizures. 

The Louisiana Court of Appeal for the Fourth circuit reversed a lower court's decision to grant a partial summary judgment motion by plaintiff Wayland Ezeb, who had argued that an earlier summary judgment decision in the dispute had established certain facts about Novartis' purported liability. 

Ezeb's suit...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.